Global Audiological Devices Market Size, Share, Development, Growth and Demand Forecast to 2023

The global audiological devices market is growing significantly due tointroduction of waterproof and wireless hearing aids, increasing need for aesthetically fabricated hearing aids, and increasing government initiatives to provide better healthcare services in the industry. Massive unexplored market in audiological devices industry of developing economies are creating ample opportunities for the audiological devices market to grow at a considerable rate during the forecasted years.

Request for Sample Copy of this Research Report At: https://www.psmarketresearch.com/market-analysis/audiological-devices-market/report-sample

Hearing impairment is usually due to genetic predisposition and chronic ear infection. Increasing prevalence of hearing problems is also fueling the growth of the market in the coming years. According to World Health Organization, globally approximately 360 million people were disabled with hearing loss in 2012. 

On the basis of product type of audiological devices, the market can be categorized as hearing aids, diagnostic devices, bone anchored hearing aids, and cochlear implants. Hearing aids lead the market in terms of market size, as it is user friendly and comfortable; whereas, cochlear implants are expected to grow at a faster rate in the coming years due to technological advancement.

Types of hearing aids include receiver-in-the-ear aids, behind-the-ear (BTE) aids, canal hearing aids (in-the-canal, completely-in-canal, and invisible-in-canal), in-the-ear (ITE) aids, and others. Behind-the-ear aid is the most popular hearing aid, as it is efficient in treating wide extend of hearing loss and is majorly preferred by elderly people due to its easiness to handle and clean.

Geographically, Europewill be leading the global audiological devices market in the coming years, due to propitious reimbursement policies, increasing government support and introduction of innovative products. Asia-Pacific is the fastest growing region in the global audiological devices market. The major reasons for the fastest growth of audiological devices market in the region are increasing healthcare expenditure, large pool of patients, increasing government support, improving healthcare infrastructure, and increasing incidence of deafness in the region. Moreover, the audiological devices market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China, of Asia-Pacific region.

Some of the companies operating in the global audiological devices market are Siemens Healthcare, Cochlear Limited, Widex A/S, Bernafon, Sonova Holdings AG, SeboTek Haring Systems, GN ReSound Group, William Demant Holding A/S, Beltone, and Starkey Hearing Technologies.

Request for Sample Copy of this Research Report At: https://www.psmarketresearch.com/market-analysis/audiological-devices-market/report-sample

Asia-Pacific Hospital Beds Market Size, Share, Development, Growth and Demand Forecast, 2012-2022

The Asia-Pacific hospital beds market size was $1.3 billion in 2015 and is forecasted to grow at a CAGR of 5.2% during the period 2016-2022. General beds have been witnessing the fastest growth, and are projected to grow at a CAGR of 5.6%, during the forecast period, among the various types of beds available in the market namely, birthing beds, pediatric beds, bariatric beds, pressure relief beds and others.

Request for Sample Copy of this Research Report At: https://www.psmarketresearch.com/market-analysis/asia-pacific-hospital-beds-market/report-sample

Some of the significant factors driving the hospital beds market in the region include, surge in the aging population, rising prevalence of chronic diseases, and improving hospital infrastructure.

Hospital beds are being utilized for various types of treatments such as acute care, critical care and long-term beds, acute care beds held the largest share of the hospital beds market in the region, in 2015.

Increase in diabetes causes numerous diseases to a human being such as cardiovascular diseases, nerve damage, kidney damage, skin conditions and others, due to which the patients need to be admitted in the hospital at times for monitoring and treatment. According to the Asian Diabetes Prevention Initiative, around 60% of diabetics in the world live in Asia. 

Due to rising population and increasing prevalence of diseases the Indian government has been taking initiatives to set up new hospitals, which will increase the requirement of hospital beds in the country. For instance, National Rural Health Mission (NHM) has allocated a ₹26,690-crore budget to revitalize rural and urban health sectors. As on July 2017, 55 new medical colleges had been approved. Funds amounting to ₹4357.42 crore have been released to the state governments/UT administrations. A part of these funds will be allocated for hospital beds.

Some of the key players operating in the Asia-Pacific hospital bed industry are Hill-Rom Holdings Inc., Stryker Corporation, Paramount Bed Co. Ltd., SEAHONENCE, INC., FRANCE BED HOLDINGS Co. Ltd., Guangdong Kareway Medical Technology Co. Ltd., Jiangsu Aegean Technology Co. Ltd., Midmark Corporation, Nanning Passion Medical Equipment Co. Ltd. and Carevel Medical Systems Private Limited.

Request for Sample Copy of this Research Report At: https://www.psmarketresearch.com/market-analysis/asia-pacific-hospital-beds-market/report-sample

Artificial Retina Market by Types of Retinal Implant - Global Growth and Development Forecast to 2013-2023

The artificial retina market is primarily driven by the increasing developments associated with sub retinal implants for the treatment of retinitis pigmentosa (RP). Sub retinal implants are placed behind the retina and have proven to be safe and restore useful vision to a majority of patients who are blind because of RP. 

Request for Sample Copy of this Research Report At: https://www.psmarketresearch.com/market-analysis/artificial-retina-market/report-sample

Artificial retina is an implant which consists of an array of micro-electrodes and is used for the individuals who are visually impaired due to retinal diseases. The progress of artificial retina is to restore limited vision that enables people to read during mobility and to recognize individuals. Artificial retina has proved to be a breakthrough invention for the medical device industry, as it has provided hope to a large number of visually impaired patients globally.

Retinal implants hold the promise of restoring vision with tiny prosthetic devices that capture light, convert it into electrical signals and then stimulate the neurons in the retina so that the brain can form an image. Retinal implants are used to treat AMD and RP and are generally used in multi-speciality hospitals, ophthalmic clinics, and research institutes.

The growing market for retinal implants is helping several start-ups to invest in this sectors as this a very lucrative segment due to increasing retinal diseases. Moreover, several reimbursement policies are being provided for surgeries of retinal implant. For instance, Retina Implant AG, based in Reutlingen, Germany, is focused on sub retinal implant technology. The company claims to be the first to have a fully functioning electronic retinal prosthesis to restore partial sight to the blind. Also, in March, 2016, the company secured a 28.2 million (€26 million) financing to establish clinical centers globally and to pursue reimbursement for its CE marked Alpha IMS sub retinal microchip.

The players in artificial retina market are in the process of receiving the CE approval for the artificial retinal implants. For instance, in September 2017, Pixium Vision, announced that it has received CE approval from European Medicines Agency (EMA) on its epi-retinal IRISII system, for outer retinal degeneration, including Retinitis Pigmentosa.

Some of the key players operating in the artificial retina industry include Nano Retina, Second Sight Medical Products, Inc., Optobionics, Aetna Inc., Pixium Vision, Retina Implant AG and Bionic Vision Technologies Pty Ltd.

Request for Sample Copy of this Research Report At: https://www.psmarketresearch.com/market-analysis/artificial-retina-market/report-sample

Global Analgesic Infusion Pumps Market Size - Growth and Demand Forecast to 2023

Analgesic infusion pumps are instruments used to carry analgesic drugs directly into patient’s body directly for pain management. Analgesic drugs provide relief from chronic disorders, including complex regional pain syndrome (CRPS), failed back syndrome pain, myocardial infarction, pneumonia, myocardial ischemia, post-operative pain, and hypertension. Lidocaine, phenol and morphine are some of the common medicines used in analgesic infusion pumps. 

Explore Report At: https://www.psmarketresearch.com/market-analysis/analgesic-infusion-pumps-market/report-sample

On the basis of different product classes, analgesia infusion pumps market can be broadly categorized as ambulatory analgesia infusion pumps, syringe analgesia infusion pumps and volumetric analgesia infusion pumps. On the basis of end users, the global analgesia infusion pumps market can be categorized as hospitals and home care. And in terms of application, the analgesia infusion pumps market can be segmented as post-surgery application, labor pain, accident and trauma, and cancer patients.

Ageing population of the western countries, rising incidences of chronic diseases, technological advancements in the field of precision and accuracy, rising application of infusion pumps and growing home care market for infusion systems are the growth drivers for analgesia infusion pumps market.

Globally, North America is the largest market for analgesic infusion pumps, and followed by Europe. Presence of well-developed healthcare infrastructure, high acceptance of technologically superior products and increasing adoption rates are the major factor behind the dominance of North America in analgesia infusion pumps market.

Some of the key competitors of analgesic infusion pumps market are B. Braun Melsungen AG, KD Scientific Inc., Animas Corporation, Hospira Inc., Terumo Corporation, Codman & Shurtleff Inc., Stryker Corp., Medtronic Inc., and Smiths Medical.

Explore Report At: https://www.psmarketresearch.com/market-analysis/analgesic-infusion-pumps-market/report-sample

Global Medical Bionics Market Size to Reach $28.1 Billion by 2023

The different types of products available in the medical bionics market are heart, neural/brain, ear, orthopedic, vision/eye and other bionics. Among these, heart bionics are expected to attain the largest share in the market, with more than 40.0% contribution in 2017. This leading position of the category is attributed to increasing cardiac problems globally. For instance, an estimated 17.7 million people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Request for Sample of this Research Report At: https://www.psmarketresearch.com/market-analysis/medical-bionics-market/report-sample

During the forecast period, the medical bionics industry is expected to witness the fastest growth in Asia-Pacific (APAC), owing to the expanding size of diabetic patients, growing aging population, rising number of chronic diseases, increasing healthcare expenditure and per capita income, and mounting research on medical bionics in the region.

Diabetes is one of the major causes of cardiac problems, resulting in the growth of the medical bionics industry in the region. According to Asian Diabetes Prevention Initiative (ADPI), an education website on diabetes, 60% of diabetics in the world live in Asia. It is also expected that without intervention, both China and India together will have almost half a billion of population suffering from diabetes, by 2030.

Globally, key players in the medical bionics market are launching new and technologically improved products to gain a larger market share. 

Also, in the same month, Cochlear Ltd. launched Baha SoundArc, a new hearing solution for people who live with conductive hearing loss, mixed hearing loss, or single-sided sensorineural deafness (SSD). It is a non-surgical behind-the-head band that works together with all of Cochlear’s Baha 5 sound processors.

Read More About this Report At: https://www.psmarketresearch.com/press-release/medical-bionics-market

Asia-Pacific (APAC) - Fastest Growing Market for Skincare Devices

The growth in the skincare devices market will be led by increasing cases of skin cancer and skin related disorders, technological advancements in skincare devices, increase in disposable income, rising demand for aesthetic procedures, and growing geriatric population.

Explore Report At: https://www.psmarketresearch.com/market-analysis/skin-care-devices-market/report-sample

Skin treatment devices held the largest share in the skincare devices market in 2017. These devices include light/LED therapy and photorejuvenation, liposuction, electrosurgical, laser based, cryotherapy, microdermabrasion, and others. Light/LED therapy and photorejuvenation devices are estimated to capture the largest share of the skin treatment devices market in 2017. This is due to the worldwide growth in aging population, and increasing popularity of these devices as a way to fight acne, and many signs of aging. Laser based devices are expected to witness the fastest growth in demand, at a CAGR of 11.9% during the forecast period.

The skincare devices are expected to witness the fastest growth in demand in APAC, at a CAGR of 12.5% during the forecast period, owing to a large population, higher prevalence of skin diseases and obesity, and aging population in the region.

The key players in the skincare devices industry are developing and launching new skincare devices that are equipped with latest technology, to gain a larger market share. For instance, in May 2017, Cutera Inc. launched truSculpt 3D, a new technology in body sculpting that offers up to 24% fat reduction in a single operation.

Some of the other key players operating in the skincare devices market include Allergan plc, Merz Pharma GmbH & Co. KGaA, Syneron Medical Ltd., Michelson Diagnostic Ltd., Lumenis Ltd., PhotoMedex Inc., Alma Lasers Ltd., Hologic Inc., Panasonic Corporation, Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Co Ltd.

Global Dental Implant and Prosthetic Market - Growth and Demand Forecast to 2022

The global dental implant and prosthetic market was valued at $7,574.0 million in 2015 and it is expected to grow at a CAGR of 7.3% during 2016-2022. Among the various dental prosthetics, the bridges and crowns segment is expected to witness the fastest growth, CAGR of 7.1% during the forecast period.

Request for Sample Copy of this Research Report, Please Visit: https://www.psmarketresearch.com/market-analysis/dental-implants-market/report-sample

The information and data in the publication “Global Dental Implant and Prosthetic Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by dental implant material, dental implant procedure, and type of dental prosthetic. P&S Market Research analysts and consultants interacted with authorities from leading companies of the concerned domain to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed online and offline research.

Geographically, Europe was the largest contributor to the global market of dental implant and prosthetic in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, a CAGR of 8.0% during the forecast period. The growth is driven by growing geriatric population, increasing medical tourism, increasing dental awareness and increasing healthcare expenditure in the region.

Some of the key companies operating in the global dental implants and prosthetics market include Straumann Holding AG, DENTSPLY International Inc., Zimmer Biomet Holdings Inc., Danaher Corporation, Osstem Implants and AVINENT Implant System.

Contact:

P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com